Guru Ownership Trend
Guru Analysis for Gilead Sciences, Inc. (GILD)
Gilead Sciences, Inc. (GILD), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 15 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $595.66 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Bearish. This is evidenced by a $323.57 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Jeremy Grantham reduced exposure by 68.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Gilead Sciences, Inc. (GILD)
Major holders include Renaissance Technologies (RenTech) ($300 M), Cliff Asness ($162.09 M), Joel Greenblatt ($52.38 M). According to the latest reported data, 15 tracked investment managers collectively hold approximately 4.43 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $323.57 M, with 3 managers increasing positions and 11 managers reducing holdings.
During the most recent reporting period, 11 managers trimmed their positions, while 0 fully exited GILD. The total reported sell value was $343.62 M.
Yes, 2 managers opened new positions in GILD, and 1 increased their existing holdings. The total reported buy value was $20.05 M.
